ClinicalTrials.govpublic full text
Becotatug Vedotin Plus Pucotenlimab and Capecitabine Followed by Concurrent Chemoradiotherapy-Immunotherapy for Locally Advanced Squamous Cell Carcinoma of the Anal Canal
squamous cell carcinoma of the anal canal, becotatug bedotin, pucotenlimab, induction therapy, chemoradiotherapy-immunotherapy, maintenance therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 914425
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.